$15.50
0.140.91%
Last update: Nov 9, 4:21 PM
Ascentage Pharma Group International
AAPGNASDAQ
The average analyst price target for Ascentage Pharma Group is $44.56, 184.5% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $33 to $51. The latest change came on Oct 16, 2026, when William Blair initiated coverage of Ascentage Pharma Group with an Outperform rating.
Price Target Range — 5 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
